Zojwalla Naseem 4
4 · Olema Pharmaceuticals, Inc. · Filed May 28, 2024
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-05-24−9,460→ 126,840 totalExercise: $4.87Exp: 2033-01-31→ Common Stock (9,460 underlying) - Exercise/Conversion
Common Stock
2024-05-24$4.87/sh+9,460$46,070→ 89,824 total
Footnotes (1)
- [F1]25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.